Cover Image
Market Research Report
Product code 
1018673

Asia-pacific Alopecia (Hair Loss) Treatment Market Forecast 2021-2028

Published: | Inkwood Research | 141 Pages | Delivery time: 2-3 business days

Price

Back to Top
Asia-pacific Alopecia (Hair Loss) Treatment Market Forecast 2021-2028
Published: July 19, 2021
Inkwood Research
Content info: 141 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The Asia-Pacific alopecia (hair loss) treatment market is projected to progress with a CAGR of 5.36% across the forecasting period of 2021 to 2028. The regional market's growth is mainly accredited to solid marketing strategies by pharmaceutical companies and hair clinics, consumer perception towards pleasing aesthetics, and the rising levels of air pollution.

MARKET INSIGHTS

The Asia-Pacific alopecia (hair loss) treatment market growth assessment constitutes the evaluation of Indonesia, Australia & New Zealand, Thailand, China, South Korea, India, Vietnam, Japan, and the rest of the Asia-Pacific. The younger generation in India, especially in their early 20s, are witnessing the initial signs of hair fall. Similarly, baldness, as well as premature graying, are also emerging as common problems impacting both women and men. Hair loss due to autoimmune diseases and pollution is also highly prevalent in India, as well. Therefore, companies strongly propagate topical solutions targeting hair loss.

On the other hand, Indonesia faces an increased burden of chronic conditions, such as hypothyroidism, alopecia, cancer, and others. As per the 2018 data issued by the Indonesian Ministry of Health, the country observed a dramatic rise in the incidence of chronic diseases, in addition to the associated risk factors over recent years. Moreover, the alarming increase in the country's air pollution levels have induced hair thinning, hair loss, and scalp irritation problems in adults. Hence, these drives are set to fuel the Asia-Pacific alopecia (hair loss) treatment market over the forecasted years.

COMPETITIVE INSIGHTS

Key companies operating in the market are: Sun Pharmaceutical Industries Ltd, Cipla, Taisho Pharmaceutical Co Ltd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 23923

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISE IN AUTOIMMUNE DISEASES
    • 3.1.2. HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
    • 3.1.3. UNHEALTHY DIETARY HABITS
    • 3.1.4. STRESS AND CHANGING LIFESTYLES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISK OF INFECTIONS OR SIDE EFFECTS
    • 3.2.2. HIGH COSTS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY GENDER

  • 5.1. FEMALE
  • 5.2. MALE

6. MARKET BY INDICATIONS

  • 6.1. ANDROGENIC ALOPECIA
  • 6.2. ALOPECIA AREATA
  • 6.3. ALOPECIA TOTALIS
  • 6.4. OTHER INDICATIONS

7. MARKET BY DISTRIBUTION CHANNELS

  • 7.1. DRUG STORES & RETAIL PHARMACIES
  • 7.2. HOSPITAL PHARMACIES
  • 7.3. ONLINE PHARMACIES

8. MARKET BY TREATMENT

  • 8.1. TOPICAL
    • 8.1.1. MINOXIDIL
    • 8.1.2. SHAMPOOS
  • 8.2. ORAL
    • 8.2.1. FINASTERIDE
    • 8.2.2. OTHER ORAL HAIR LOSS TREATMENT
  • 8.3. OTHER TREATMENT TYPES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. ASIA-PACIFIC
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. CHINA
      • 9.1.5.2. JAPAN
      • 9.1.5.3. INDIA
      • 9.1.5.4. SOUTH KOREA
      • 9.1.5.5. INDONESIA
      • 9.1.5.6. THAILAND
      • 9.1.5.7. VIETNAM
      • 9.1.5.8. AUSTRALIA & NEW ZEALAND
      • 9.1.5.9. REST OF ASIA-PACIFIC

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS & AGREEMENTS
    • 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 10.2. COMPANY PROFILES
    • 10.2.1. ACLARIS THERAPEUTICS
    • 10.2.2. CELLMID
    • 10.2.3. CIPLA LTD
    • 10.2.4. CONCERT PHARMACEUTICALS
    • 10.2.5. DAIICHI SANKYO
    • 10.2.6. DR. REDDY'S LABORATORIES
    • 10.2.7. JOHNSON AND JOHNSON
    • 10.2.8. LEXINGTON INTERNATIONAL
    • 10.2.9. MERK & CO INC
    • 10.2.10. SHISEIDO COMPANY LIMITED
    • 10.2.11. SUN PHARMACEUTICAL INDUSTRIES LTD
    • 10.2.12. TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
    • 10.2.13. TEVA PHARMACEUTICALS INDUSTRIES LTD
    • 10.2.14. THE HIMALAYA DRUG COMPANY
    • 10.2.15. TRANSITION HAIR PVT LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • TABLE 2: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: LEADING PLAYERS OPERATING IN ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • TABLE 17: LIST OF MERGERS & ACQUISITIONS
  • TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
  • FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
  • FIGURE 7: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
  • FIGURE 8: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
  • FIGURE 9: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020
  • FIGURE 10: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
  • FIGURE 11: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
  • FIGURE 12: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020
  • FIGURE 15: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 17: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020
  • FIGURE 19: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 21: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
  • FIGURE 22: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
  • FIGURE 24: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 25: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
  • FIGURE 26: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 27: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 28: ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 29: CHINA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: JAPAN ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: INDIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: SOUTH KOREA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: INDONESIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: THAILAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: VIETNAM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: AUSTRALIA & NEW ZEALAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: REST OF ASIA-PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)